[go: up one dir, main page]

NO20003964L - Tredimensjonale strukturer og modeller av Fc reseptorer og anvendelser derav - Google Patents

Tredimensjonale strukturer og modeller av Fc reseptorer og anvendelser derav

Info

Publication number
NO20003964L
NO20003964L NO20003964A NO20003964A NO20003964L NO 20003964 L NO20003964 L NO 20003964L NO 20003964 A NO20003964 A NO 20003964A NO 20003964 A NO20003964 A NO 20003964A NO 20003964 L NO20003964 L NO 20003964L
Authority
NO
Norway
Prior art keywords
receptors
models
applications
dimensional structures
dimensional
Prior art date
Application number
NO20003964A
Other languages
English (en)
Other versions
NO20003964D0 (no
Inventor
P Mark Hogarth
Maree S Powell
Ian F Mckenzie
Kelly F Maxwell
Thomas P J Garett
Vidana Epa
Jonathan B Baell
Barry R Matthews
Thomas D Mccarthy
Geoffrey A Pietersz
Original Assignee
Ilexus Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ilexus Pty Ltd filed Critical Ilexus Pty Ltd
Publication of NO20003964D0 publication Critical patent/NO20003964D0/no
Publication of NO20003964L publication Critical patent/NO20003964L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70535—Fc-receptors, e.g. CD16, CD32, CD64 (CD2314/705F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2299/00—Coordinates from 3D structures of peptides, e.g. proteins or enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Processing Or Creating Images (AREA)
NO20003964A 1998-02-06 2000-08-04 Tredimensjonale strukturer og modeller av Fc reseptorer og anvendelser derav NO20003964L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7397298P 1998-02-06 1998-02-06
US9999498P 1998-09-11 1998-09-11
PCT/IB1999/000367 WO1999040117A1 (en) 1998-02-06 1999-02-04 THREE-DIMENSIONAL STRUCTURES AND MODELS OF Fc RECEPTORS AND USES THEREOF

Publications (2)

Publication Number Publication Date
NO20003964D0 NO20003964D0 (no) 2000-08-04
NO20003964L true NO20003964L (no) 2000-10-04

Family

ID=26755120

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20003964A NO20003964L (no) 1998-02-06 2000-08-04 Tredimensjonale strukturer og modeller av Fc reseptorer og anvendelser derav

Country Status (16)

Country Link
US (2) US6675105B2 (no)
EP (1) EP1053255A4 (no)
JP (1) JP2004510681A (no)
KR (1) KR20010024899A (no)
CN (1) CN1291198A (no)
AP (1) AP2000001876A0 (no)
AU (1) AU759378B2 (no)
BR (1) BR9907964A (no)
CA (1) CA2316860A1 (no)
EA (1) EA200000746A1 (no)
IL (1) IL137583A0 (no)
NO (1) NO20003964L (no)
NZ (1) NZ505914A (no)
PL (1) PL342297A1 (no)
TR (1) TR200002271T2 (no)
WO (1) WO1999040117A1 (no)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7553809B2 (en) 1998-02-06 2009-06-30 Ilexus Pty Limited Fc receptor modulators and uses thereof
JP2002524504A (ja) * 1998-09-11 2002-08-06 イレクサス・ピーティーワイ・リミテッド Ｆｃ受容体調節剤およびそれの使用
CA2349410A1 (en) * 1998-11-05 2000-05-11 Heska Corporation Crystallized form of fc epsilon receptor alpha chain, its 3-d model and uses thereof
EP1006183A1 (en) * 1998-12-03 2000-06-07 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Recombinant soluble Fc receptors
US7912689B1 (en) 1999-02-11 2011-03-22 Cambridgesoft Corporation Enhancing structure diagram generation through use of symmetry
US7295931B1 (en) * 1999-02-18 2007-11-13 Cambridgesoft Corporation Deriving fixed bond information
US6850876B1 (en) * 1999-05-04 2005-02-01 Smithkline Beecham Corporation Cell based binning methods and cell coverage system for molecule selection
US6889145B1 (en) 2000-03-15 2005-05-03 Northwestern University Three-dimensional model of a Fc region of an IgE antibody and uses thereof
US7356419B1 (en) 2000-05-05 2008-04-08 Cambridgesoft Corporation Deriving product information
US7272509B1 (en) * 2000-05-05 2007-09-18 Cambridgesoft Corporation Managing product information
IL144082A0 (en) * 2000-07-14 2002-05-23 Medical Res Council Crystal structure of antibiotics bound to the 30s ribosome and its use
GB0029871D0 (en) * 2000-07-14 2001-01-24 Medical Res Council Crystal structure (V)
EP1201681A1 (en) * 2000-10-30 2002-05-02 Millennium Pharmaceuticals, Inc. "Fail" molecules and uses thereof
CN1245215C (zh) 2001-02-28 2006-03-15 四川省生物工程研究中心 重组高效复合干扰素用作乙型肝炎表面抗原和e抗原抑制剂
MXPA03009580A (es) * 2001-04-20 2004-12-06 Sinai School Medicine Tir3, un receptor de sabor novedoso.
US7803982B2 (en) 2001-04-20 2010-09-28 The Mount Sinai School Of Medicine Of New York University T1R3 transgenic animals, cells and related methods
US20100056762A1 (en) 2001-05-11 2010-03-04 Old Lloyd J Specific binding proteins and uses thereof
CA2447139C (en) * 2001-05-11 2013-11-19 Ludwig Institute For Cancer Research Specific binding proteins and uses thereof
DE10157290A1 (de) * 2001-11-22 2003-06-05 Max Planck Gesellschaft Pharmazeutische Zusammensetzung enthaltend sFcRgamma IIb oder sFcRgamma III
EP1495432A2 (en) * 2002-04-10 2005-01-12 TransTech Pharma Inc. System and method for data analysis, manipulation, and visualization
AU2002953533A0 (en) 2002-12-24 2003-01-16 Arthron Limited Fc receptor modulating compounds and compositions
BRPI0406724A (pt) 2003-01-13 2005-12-20 Macrogenics Inc Proteìna de fusão dimérica, métodos de tratar, prevenir ou melhorar um ou mais sintomas de um distúrbio autoimune e um ou mais sintomas de púrpura trombocitopênica idiopática, composição farmacêutica, ácido nucleico, vetor, célula hospedeira, método de produzir recombinantemente o polipeptìdeo, polipeptìdeo isolado, fragmento de qualquer um dos polipeptìdeos, e, molécula de ácido nucleico isolada
NZ543430A (en) * 2003-05-26 2008-06-30 Biotie Therapies Corp Crystalline VAP-1 and uses thereof
US7585647B2 (en) 2003-08-28 2009-09-08 Guangwen Wei Nucleic acid encoding recombinant interferon
EP1718672A4 (en) * 2004-02-10 2009-11-25 Austin Research Inst CRYSTALLINE STRUCTURES AND MODELS FOR FC RECEPTORS AND USES THEREOF FOR DESIGNING AND IDENTIFYING MODULATING COMPOUNDS OF FC RECEPTORS
WO2006133486A1 (en) * 2005-06-14 2006-12-21 The Macfarlane Burnet Institute For Medical Research And Public Health Limited CRYSTAL STRUCTURES AND MODELS FOR Fc RECEPTOR:Fc COMPLEXES AND USES THEREOF
WO2008103474A1 (en) * 2007-02-20 2008-08-28 Anaptysbio, Inc. Methods of generating libraries and uses thereof
EP2567338B1 (en) * 2010-05-03 2020-04-08 Perkinelmer Informatics, Inc. Method and apparatus for processing documents to identify chemical structures
MX340498B (es) 2011-06-30 2016-07-11 Chugai Pharmaceutical Co Ltd Polipeptido heterodimerizado.
JP6226752B2 (ja) 2012-02-09 2017-11-08 中外製薬株式会社 抗体のＦｃ領域改変体
US9977876B2 (en) 2012-02-24 2018-05-22 Perkinelmer Informatics, Inc. Systems, methods, and apparatus for drawing chemical structures using touch and gestures
WO2013187495A1 (ja) 2012-06-14 2013-12-19 中外製薬株式会社 改変されたFc領域を含む抗原結合分子
RU2729831C2 (ru) 2012-08-24 2020-08-12 Чугаи Сейяку Кабусики Кайся ВАРИАНТЫ FcγRIIB-СПЕЦИФИЧЕСКОЙ Fc-ОБЛАСТИ
US9535583B2 (en) 2012-12-13 2017-01-03 Perkinelmer Informatics, Inc. Draw-ahead feature for chemical structure drawing applications
JP6433297B2 (ja) 2012-12-27 2018-12-05 中外製薬株式会社 ヘテロ二量化ポリペプチド
CA2895567C (en) 2013-03-13 2023-10-10 Perkinelmer Informatics, Inc. Systems and methods for gesture-based sharing of data between separate electronic devices
US8854361B1 (en) 2013-03-13 2014-10-07 Cambridgesoft Corporation Visually augmenting a graphical rendering of a chemical structure representation or biological sequence representation with multi-dimensional information
KR20210130260A (ko) 2013-04-02 2021-10-29 추가이 세이야쿠 가부시키가이샤 Ｆｃ영역 개변체
US9430127B2 (en) 2013-05-08 2016-08-30 Cambridgesoft Corporation Systems and methods for providing feedback cues for touch screen interface interaction with chemical and biological structure drawing applications
US9751294B2 (en) 2013-05-09 2017-09-05 Perkinelmer Informatics, Inc. Systems and methods for translating three dimensional graphic molecular models to computer aided design format
CA3041717A1 (en) 2016-11-09 2018-05-17 North Carolina State University Treatment of allergic diseases with chimeric protein
JP6883120B2 (ja) 2017-03-03 2021-06-09 パーキンエルマー インフォマティクス， インコーポレイテッド 化学情報を含む文書の検索および索引付けのためのシステムおよび方法
KR101987268B1 (ko) * 2017-10-12 2019-06-10 국민대학교 산학협력단 Fc 감마 수용체 변이체 MG2A45
KR101986252B1 (ko) * 2017-09-15 2019-06-05 국민대학교 산학협력단 Fc 감마 수용체 변이체 MG2A28
KR101987272B1 (ko) * 2017-09-15 2019-06-10 국민대학교 산학협력단 Fc 감마 수용체 변이체 MG2A28.1
WO2019054782A1 (ko) * 2017-09-15 2019-03-21 국민대학교 산학협력단 Fc 감마 수용체 변이체들
KR101987279B1 (ko) * 2017-10-12 2019-06-10 국민대학교 산학협력단 Fc 감마 수용체 변이체 MG2A45.1
KR101986250B1 (ko) * 2017-09-15 2019-06-05 국민대학교 산학협력단 Fc 감마 수용체 변이체 SH2A40
KR101987292B1 (ko) * 2017-10-12 2019-06-10 국민대학교 산학협력단 Fc 감마 수용체 변이체 MG2B45.1
US12060437B2 (en) 2018-03-23 2024-08-13 North Carolina State University Methods and compositions for antibody to high affinity receptor for IgE
US12448451B2 (en) 2021-06-25 2025-10-21 Chugai Seiyaku Kabushiki Kaisha Anti-CTLA-4 antibody and use thereof
CN115035947B (zh) * 2022-06-10 2023-03-10 水木未来(北京)科技有限公司 蛋白质结构建模方法及装置、电子设备和存储介质

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5858981A (en) * 1993-09-30 1999-01-12 University Of Pennsylvania Method of inhibiting phagocytosis
JP2002524504A (ja) * 1998-09-11 2002-08-06 イレクサス・ピーティーワイ・リミテッド Ｆｃ受容体調節剤およびそれの使用
AU2001278771A1 (en) * 2000-08-22 2002-03-04 Ono Pharmaceutical Co. Ltd. Carboxylic acid derivatives, process for producing the same and drugs containingthe same as the active ingredient

Also Published As

Publication number Publication date
WO1999040117A1 (en) 1999-08-12
AU759378B2 (en) 2003-04-10
TR200002271T2 (tr) 2000-11-21
US20020107359A1 (en) 2002-08-08
PL342297A1 (en) 2001-06-04
AP2000001876A0 (en) 2000-09-30
AU2438299A (en) 1999-08-23
JP2004510681A (ja) 2004-04-08
NZ505914A (en) 2004-03-26
EA200000746A1 (ru) 2001-04-23
CA2316860A1 (en) 1999-08-12
BR9907964A (pt) 2000-10-17
IL137583A0 (en) 2001-07-24
EP1053255A1 (en) 2000-11-22
US6675105B2 (en) 2004-01-06
NO20003964D0 (no) 2000-08-04
CN1291198A (zh) 2001-04-11
EP1053255A4 (en) 2003-01-02
KR20010024899A (ko) 2001-03-26
US20040054480A1 (en) 2004-03-18

Similar Documents

Publication Publication Date Title
NO20003964L (no) Tredimensjonale strukturer og modeller av Fc reseptorer og anvendelser derav
DE69531681D1 (de) Spielbaustein-Set aus flexiblem Schaumstoff
FI973419L (fi) Epäorgaanisten aerogeelien käyttö lääkkeiden valmistuksessa
PT1270565E (pt) Furano-2-sulfonamida 4-substituida e sua utilizacao na preparacao de derivados de sulfonilureia
DE60020795D1 (de) Echtzeitmodellierung des Verhaltens menschlicher Sehvermögenssysteme
DE60219242D1 (de) Dreidimensionales Rechnermodellierungsgerät
DE60238926D1 (de) Gleichzeitige benutzung von 2d- und 3d-modellierungsdaten
NO993338D0 (no) Fremstilling av mönstrede abrasive overflater
DE59915101D1 (de) Kombinationen aus Herbiziden und Safenern
DE59907567D1 (de) Kombinationen aus herbiziden und safenern
NO20005343L (no) Fastsettelse av formen og orienteringen til et borehull
NO20004752L (no) Flerlags plastrør og bruk av samme
DE69729694D1 (de) Anbringbarer und entfernbarer Stent aus Formgedächtnisplastik
NO20013665D0 (no) Kaliumsalt av (S)-omeprazol
NO20025758D0 (no) Anvendelse av skrueviklet rörkonstruksjon i brönnmiljöet
NO996281L (no) Bestemmelse av seismisk polaranisotropi
NO985549D0 (no) Akustisk bygge-element
EP1476150A4 (en) CARBOXY FULLERES AND USE METHOD THEREFOR
KR960009147A (ko) 전자 메모리와 이의 제조 및 사용 방법
EP1451587A4 (en) ANTIGENTAFELN AND METHOD FOR THEIR USE
NO20012011D0 (no) Fremstilling og anvendelse av stivnede oljer
NO20023144D0 (no) Kompleks omfattende OCIF og polysakkarid
DE69919941D1 (de) Modellierungsverfahren und Simulationsverfahren
EP1263935A4 (en) SCYTONEMIN AND METHODS OF ITS USE
FR2827041B1 (fr) Dispositif piezoresistif et procedes de fabrication de ce dispositif

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application